Drug Profile
Research programme: PPAR agonists - Bristol-Myers Squibb
Alternative Names: BMS-687453; BMS-711939; BMS-759509Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Bristol-Myers Squibb
- Class
- Mechanism of Action Peroxisome proliferator-activated receptor alpha agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Atherosclerosis; Lipid metabolism disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Atherosclerosis in USA (PO)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Lipid-metabolism-disorders in USA (PO)
- 20 Aug 2009 Pharmacokinetics & pharmacodynamics data from preclinical trials in Atherosclerosis & Lipid metabolism disorders presented at the 238th National Meeting of the American Chemical Society (ACS-2009)